• Citer

Vinorelbine and continuous low-dose cyclophosphamide as maintenance chemotherapy in patients with high-risk rhabdomyosarcoma (RMS 2005): a multicentre, open-label, randomised, phase 3 trial

par Bisogno, Gianni;De Salvo, Gian Luca;Bergeron, Christophe;Gallego Melcón, Soledad;Merks, Johannes H M;Kelsey, Anna;Martelli, Helene;Minard-Colin, Véronique;Orbach, Daniel;Glosli, Heidi;Chisholm, Julia;Casanova, Michela;Zanetti, Ilaria;Devalck, Christine ;Ben-Arush, Myriam;Mudry, Peter;Ferman, Sima;Jenney, Meriel;Ferrari, Andrea
Référence Lancet oncology, 20, 11, page (1566-1575)
Publication Publié, 2019-11-01

Article révisé par les pairs

• Accès en ligne
• Détails
• Contenu
• Statistiques

Titre:	Vinorelbine and continuous low-dose cyclophosphamide as maintenance chemotherapy in patients with high-risk rhabdomyosarcoma (RMS 2005): a multicentre, open-label, randomised, phase 3 trial
Auteur:	Bisogno, Gianni; De Salvo, Gian Luca; Bergeron, Christophe; Gallego Melcón, Soledad; Merks, Johannes H M; Kelsey, Anna; Martelli, Helene; Minard-Colin, Véronique; Orbach, Daniel; Glosli, Heidi; Chisholm, Julia; Casanova, Michela; Zanetti, Ilaria; Devalck, Christine; Ben-Arush, Myriam; Mudry, Peter; Ferman, Sima; Jenney, Meriel; Ferrari, Andrea
Informations sur la publication:	Lancet oncology, 20, 11, page (1566-1575)
Statut de publication:	Publié, 2019-11-01
Sujet CREF:	Cancérologie
Note générale:	SCOPUS: ar.j
Langue:	Anglais
Identificateurs:	urn:issn:1470-2045
	info:doi/10.1016/S1470-2045(19)30617-5
	info:pii/S1470204519306175
	info:scp/85074098509
	info:pmid/31562043